These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10070953)
41. Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Reedy M; Gallion H; Fowler JM; Kryscio R; Smith SA Gynecol Oncol; 2002 May; 85(2):255-9. PubMed ID: 11972384 [TBL] [Abstract][Full Text] [Related]
42. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Thorlacius S; Olafsdottir G; Tryggvadottir L; Neuhausen S; Jonasson JG; Tavtigian SV; Tulinius H; Ogmundsdottir HM; Eyfjörd JE Nat Genet; 1996 May; 13(1):117-9. PubMed ID: 8673089 [TBL] [Abstract][Full Text] [Related]
43. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595 [TBL] [Abstract][Full Text] [Related]
44. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Nordling M; Karlsson P; Wahlström J; Engwall Y; Wallgren A; Martinsson T Cancer Res; 1998 Apr; 58(7):1372-5. PubMed ID: 9537232 [TBL] [Abstract][Full Text] [Related]
45. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425 [TBL] [Abstract][Full Text] [Related]
46. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Friedman LS; Gayther SA; Kurosaki T; Gordon D; Noble B; Casey G; Ponder BA; Anton-Culver H Am J Hum Genet; 1997 Feb; 60(2):313-9. PubMed ID: 9012404 [TBL] [Abstract][Full Text] [Related]
47. Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family. Diez O; Gutiérrez-Enríquez S; Masas M; Tenés A; Yagüe C; Arcusa A; Llort G Breast Cancer Res Treat; 2010 Sep; 123(2):587-90. PubMed ID: 20232139 [TBL] [Abstract][Full Text] [Related]
48. BRCA2 germ-line mutations in Spanish male breast cancer patients. Díez O; Cortés J; Domènech M; Pericay C; Brunet J; Alonso C; Baiget M Ann Oncol; 2000 Jan; 11(1):81-4. PubMed ID: 10690392 [TBL] [Abstract][Full Text] [Related]
49. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Malone KE; Daling JR; Neal C; Suter NM; O'Brien C; Cushing-Haugen K; Jonasdottir TJ; Thompson JD; Ostrander EA Cancer; 2000 Mar; 88(6):1393-402. PubMed ID: 10717622 [TBL] [Abstract][Full Text] [Related]
50. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Håkansson S; Johannsson O; Johansson U; Sellberg G; Loman N; Gerdes AM; Holmberg E; Dahl N; Pandis N; Kristoffersson U; Olsson H; Borg A Am J Hum Genet; 1997 May; 60(5):1068-78. PubMed ID: 9150154 [TBL] [Abstract][Full Text] [Related]
51. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438 [TBL] [Abstract][Full Text] [Related]
52. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer. Balci A; Huusko P; Pääkkönen K; Launonen V; Uner A; Ekmekçi A; Winqvist R Eur J Cancer; 1999 May; 35(5):707-10. PubMed ID: 10505028 [TBL] [Abstract][Full Text] [Related]
53. Genetic analyses of male breast cancer in Israel. Sverdlov RS; Barshack I; Bar Sade RB; Baruch RG; Hirsh-Yehezkel G; Dagan E; Feinmesser M; Figer A; Friedman E Genet Test; 2000; 4(3):313-7. PubMed ID: 11142766 [TBL] [Abstract][Full Text] [Related]
54. Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients. Ozdag H; Tez M; Sayek I; Müslümanoglu M; Tarcan O; Içli F; Oztürk M; Ozçelik T Eur J Cancer; 2000 Oct; 36(16):2076-82. PubMed ID: 11044644 [TBL] [Abstract][Full Text] [Related]
55. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Connor F; Bertwistle D; Mee PJ; Ross GM; Swift S; Grigorieva E; Tybulewicz VL; Ashworth A Nat Genet; 1997 Dec; 17(4):423-30. PubMed ID: 9398843 [TBL] [Abstract][Full Text] [Related]
56. Genetic testings for cancer: the surgeon's critical role. Familial breast cancer. Weber BL J Am Coll Surg; 1999 Jan; 188(1):79-86. PubMed ID: 9915248 [No Abstract] [Full Text] [Related]
58. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. Cho JH; Bang S; Park SW; Chung JB; Song SY Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078 [TBL] [Abstract][Full Text] [Related]
59. Roads leading to breast cancer. Haber D N Engl J Med; 2000 Nov; 343(21):1566-8. PubMed ID: 11087889 [No Abstract] [Full Text] [Related]
60. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Ramus SJ; Kote-Jarai Z; Friedman LS; van der Looij M; Gayther SA; Csokay B; Ponder BA; Olah E Am J Hum Genet; 1997 May; 60(5):1242-6. PubMed ID: 9150174 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]